Jump to section
To empower the genomic data ecosystem that underpins the precision medicine revolution. Zetta aims to deliver exceptional data architectures and services for healthcare professionals and researchers to optimise healthcare outcomes globally.
Zetta Genomics was spun out of Cambridge University with a vision to become the gold standard for genomic information in precision medicine.
Genomic data is notoriously challenging to work with due to reliance on data files that cannot scale, are difficult to access and provide no built-in way to integrate disparate data types. By providing a modern data stack, Zetta Genomics makes this data available to researchers and practitioners.
The company is now looking to switch from a managed services model to a more developed SaaS product. Their challenge will be to build on their XetaBase platform in a fashion that continues to protect the privacy of the data while making it accessible in a user-friendly SaaS product.
Freddie
Company Specialist at Welcome to the Jungle
Feb 2024
$2.3m
SEED
Apr 2023
$2.4m
SEED
This company has top investors
Ignacio Medina
(CTO)Became Head of Computational Biology Lab at the University of Cambridge where they founded Zetta Genomics. Also Team Leader of Big Data Analytics at Genomics England.
Will Spooner
(CEO)A bioinformatics technologist, innovator and entrepreneur, Will previously co-founded Eagle Genomics and was head of innovation at Genomics England. They have worked on Ensembl, BioMart, Gramene and WormBase at EBI, the Wellcome Trust Sanger Institute and Cold Spring Harbor.